FIXR Parvo Lepto
FIXR Parvo Lepto
Authorised
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
- Leptospira borgpetersenii, serovar Hardjo, strain MSLB 1039, Inactivated
- Porcine parvovirus, strain Bio-37, Inactivated
- Leptospira interrogans, serovar Canicola, strain MSLB 1043, Inactivated
- Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1042, Inactivated
- Leptospira interrogans, serovar Bratislava, strain MSLB 1040, Inactivated
- Leptospira interrogans, serovar Pomona, strain MSLB 1037, Inactivated
Product identification
Medicine name:
FIXR Parvo Lepto
Active substance:
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
- Leptospira borgpetersenii, serovar Hardjo, strain MSLB 1039, Inactivated
- Porcine parvovirus, strain Bio-37, Inactivated
- Leptospira interrogans, serovar Canicola, strain MSLB 1043, Inactivated
- Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1042, Inactivated
- Leptospira interrogans, serovar Bratislava, strain MSLB 1040, Inactivated
- Leptospira interrogans, serovar Pomona, strain MSLB 1037, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated0.02/Antibody microagglutination-lytic reaction2.00millilitre(s)
-
Leptospira borgpetersenii, serovar Hardjo, strain MSLB 1039, Inactivated0.03/Antibody microagglutination-lytic reaction2.00millilitre(s)
-
Porcine parvovirus, strain Bio-37, Inactivated
-
Leptospira interrogans, serovar Canicola, strain MSLB 1043, Inactivated0.02/Antibody microagglutination-lytic reaction2.00millilitre(s)
-
Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1042, Inactivated0.02/Antibody microagglutination-lytic reaction2.00millilitre(s)
-
Leptospira interrogans, serovar Bratislava, strain MSLB 1040, Inactivated0.03/Antibody microagglutination-lytic reaction2.00millilitre(s)
-
Leptospira interrogans, serovar Pomona, strain MSLB 1037, Inactivated0.03/Antibody microagglutination-lytic reaction2.00millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AL
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- carton box 1 × 10 ml glass vials hydrolytic class I
- carton box 1 × 100 ml glass vials hydrolytic class II
- carton box 1 × 50 ml glass vials hydrolytic class II
- PVC box with cap with 10 holes 10 × 10 ml glass vials of hydrolytic class I
- carton box 1 × 20 ml glass vials hydrolytic class II
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Similar biological application (Article 13(4) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Kernfarm B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0335/001
Concerned member states:
-
Belgium
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.